{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:27Z","timestamp":1791925707622,"version":"4.3.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.3233\/jad-160411","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T11:06:41Z","timestamp":1474369601000},"page":"315-320","source":"Crossref","is-referenced-by-count":77,"title":["Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"55","author":[{"given":"Francesca","family":"Zimetti","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caffarra","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of Parma, Parma, Italy"},{"name":"Centre for Cognitive Disorders and Dementia (CDCD), AUSL, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Favari","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Adorni","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Zanotti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Bernini","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Barocco","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spallazzi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Galimberti","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Pathophysiology and Transplantation, University of Milano, Fondazione C\u00e0 Granda, IRCCS Ospedale Policlinico, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ricci","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Ruscica","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Corsini","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Farmacologiche e Biomolecolari, Universit\u00e0 degli Studi di Milano, Milano, Italy"},{"name":"Multimedica IRCCS, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Ferri","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze del Farmaco, Universit\u00e0 degli Studi di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160411_ref1","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1161\/CIRCULATIONAHA.115.015489","article-title":"Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease","volume":"131","author":"Desikan","year":"2015","journal-title":"Circulation"},{"key":"10.3233\/JAD-160411_ref2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-160411_ref3","doi-asserted-by":"crossref","first-page":"e44430","DOI":"10.1371\/journal.pone.0044430","article-title":"Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway","volume":"7","author":"Okoro","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160411_ref4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","article-title":"Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture","volume":"74","author":"Michikawa","year":"2000","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160411_ref5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","article-title":"HDL and cholesterol handling in the brain","volume":"103","author":"Vitali","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.3233\/JAD-160411_ref6","doi-asserted-by":"crossref","unstructured":"Ferri N , Ruscica M (2016) Proprotein convertase subtilisin\/kexin type 9 (PCSK9) and metabolic syndrome: Insights on insulin resistance, inflammation, and atherogenic dyslipidemia. Endocrine. doi: 10.1007\/s12020-016-0939-0","DOI":"10.1007\/s12020-016-0939-0"},{"key":"10.3233\/JAD-160411_ref7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tibs.2008.06.005","article-title":"PCSK9 and LDL cholesterol: Unravelling the target to design the bullet","volume":"33","author":"Costet","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"10.3233\/JAD-160411_ref8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MOL.0000000000000180","article-title":"Role of PCSK9 beyond liver involvement","volume":"26","author":"Cariou","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.3233\/JAD-160411_ref9","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160411_ref10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11745-014-3895-6","article-title":"PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day","volume":"49","author":"Chen","year":"2014","journal-title":"Lipids"},{"key":"10.3233\/JAD-160411_ref11","doi-asserted-by":"crossref","first-page":"e64145","DOI":"10.1371\/journal.pone.0064145","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)","volume":"8","author":"Canuel","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160411_ref12","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"Poirier","year":"2008","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160411_ref13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: Revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160411_ref14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-160411_ref15","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer\u2019s disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-160411_ref16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","article-title":"APOE epsilon 3\/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer\u2019s disease diagnosis","volume":"183","author":"Fukumoto","year":"2003","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-160411_ref17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/cyto.a.20346","article-title":"Proapoptotic effects of NARC 1 (=PCSK9), the gene encoding a novel serine proteinase","volume":"69","author":"Bingham","year":"2006","journal-title":"Cytometry A"},{"key":"10.3233\/JAD-160411_ref18","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3233\/JAD-160025","article-title":"PiB-PET imaging-based serum proteome profiles predict mild cognitive impairment and Alzheimer\u2019s disease","volume":"53","author":"Kang","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160411_ref19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/embor.2008.132","article-title":"PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1","volume":"9","author":"Jonas","year":"2008","journal-title":"EMBO Rep"},{"key":"10.3233\/JAD-160411_ref20","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1194\/jlr.M006635","article-title":"PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain","volume":"51","author":"Liu","year":"2010","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-160411_ref21","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/hmg\/ddq079","article-title":"Analysis of lipid pathway genes indicates association of sequence variation near SREBF1\/TOM1L2\/ATPAF2 with dementia risk","volume":"19","author":"Reynolds","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-160411_ref22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00041444-200512000-00004","article-title":"No genetic association between PCSK9 polymorphisms and Alzheimer\u2019s disease and plasma cholesterol level in Japanese patients","volume":"15","author":"Shibata","year":"2005","journal-title":"Psychiatr Genet"},{"key":"10.3233\/JAD-160411_ref23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yexcr.2016.01.001","article-title":"Stress-induced upregulation of VLDL receptor alters Wnt-signaling in neurons","volume":"340","author":"Kysenius","year":"2016","journal-title":"Exp Cell Res"},{"key":"10.3233\/JAD-160411_ref24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1194\/jlr.M014118","article-title":"PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke","volume":"52","author":"Rousselet","year":"2011","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-160411_ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-beta1-42 across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-160411_ref26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2015.12.004","article-title":"Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"360","author":"Talwar","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160411_ref27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","article-title":"APOE epsilon4: The most prevalent yet understudied risk factor for Alzheimer\u2019s disease","volume":"10","author":"Michaelson","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160411_ref28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1523\/JNEUROSCI.3562-15.2016","article-title":"Direct transcriptional effects of apolipoprotein E","volume":"36","author":"Theendakara","year":"2016","journal-title":"J Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:11Z","timestamp":1777370651000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":28,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-160411","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}